Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation - No Study Results Posted

Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver Transplantation (Nabi-HB-SC)

This study has been withdrawn prior to enrollment.

( New sponsor's existing product under evaluation for this indication )

Study NCT00800787 Information provided by Biotest Pharmaceuticals Corporation

First Received: November 26, 2008 Last Updated: June 29, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study was withdrawn before participants were enrolled.

Study Status:	This study has been withdrawn prior to enrollment.
Estimated Study Completion Date:	September 2010
Estimated Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)